Journal
JOURNAL OF INFECTION AND CHEMOTHERAPY
Volume 15, Issue 1, Pages 39-41Publisher
SPRINGER TOKYO
DOI: 10.1007/s10156-008-0654-8
Keywords
Pneumonia; Bacillus cereus; Metallo-beta-lactamase; AML
Categories
Ask authors/readers for more resources
Bacillus cereus is known as a serious bacterial pathogen in neutropenic patients. B. cereus is often resistant to beta-lactams, including penicillins and cephalosporins. We report a case of fatal pneumonia caused by B. cereus in a patient with newly diagnosed acute myeloid leukemia (AML) during remission induction therapy. Cefepime was started for febrile neutropenia (FN) initially and was switched to panipem/betamipron, when fulminant pneumonia supervened. The isolated strain was resistant not only to cefepime but also to panipenem/betamipron. This is the first report of fulminant infection caused by carbapenem-resistant B. cereus in a neutropenic patient. B. cereus should be kept in mind as a target of empirical treatment when neutropenic patients develop pneumonia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available